TFX

Teleflex
NYSE

Real-time Quotes | Nasdaq Last Sale

339.35
-10.65
-3.04%
Opening 12:32 05/27 EDT
OPEN
352.04
PREV CLOSE
350.00
HIGH
352.04
LOW
335.19
VOLUME
174.97K
TURNOVER
--
52 WEEK HIGH
398.65
52 WEEK LOW
221.27
MARKET CAP
15.75B
P/E (TTM)
29.04
1D
5D
1M
3M
1Y
5Y

Analyst Rating

Based on 13 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target

The average TFX stock price target is 387.73 with a high estimate of 431.00 and a low estimate of 334.00.

EPS

TFX News

More
Teleflex Incorporated -- Moody's assigns Ba3 rating to Teleflex's new unsecured notes
Moody's Investors Service, ("Moody's") assigned a Ba3 rating to Teleflex Incorporated's ("Teleflex") proposed $500 million senior unsecured note offering due 2028. There are no changes to Teleflex's existing ratings, including the Ba2 Corporate Family Rating,
Moody's · 6d ago
Teleflex Incorporated Announces Private Offering of $500 Million of Senior Notes due 2028
The Notes will be guaranteed by each of Teleflex’s existing and future wholly-owned domestic subsidiaries that is a guarantor or other obligor under its credit agreement. Teleflex intends to use the net proceeds from the offering to repay borrowings under its
GlobeNewswire · 6d ago
Teleflex Incorporated -- Moody's announces completion of a periodic review of ratings of Teleflex Incorporated
Moody's Investors Service ("Moody's") has completed a periodic review of the ratings of Teleflex Incorporated and other ratings that are associated with the same analytical unit. The review was conducted through a portfolio review in which Moody's reassessed
Moody's · 6d ago
Eiger NDA Accepted, And Other News: The Good, Bad And Ugly Of Biopharma
Seeking Alpha - Article · 6d ago
IPO Update: Inari Medical Proposes IPO Terms
Seeking Alpha - Article · 05/18 18:15
Teleflex up 5% on positive UroLift data
Seeking Alpha - Article · 05/18 14:56
Teleflex Announces Positive Data Showing that the UroLift® System Effectively Relieves Enlarged Prostate Symptoms While Preserving Patients’ Sexual Function*
Data Presented at American Urological Association 2020 Virtual Experience Highlight Benefits and Superior Sexual Function* Preservation of the Minimally Invasive Treatment for.
GlobeNewswire · 05/18 10:30
Edited Transcript of TFX earnings conference call or presentation 30-Apr-20 12:00pm GMT
Q1 2020 Teleflex Inc Earnings Call
Thomson Reuters StreetEvents · 05/17 22:51

Industry

Medical Equipment, Supplies & Distribution
-0.68%
Healthcare Equipment & Supplies
-0.62%

Hot Stocks

Symbol
Price
%Change

About TFX

Teleflex Incorporated is a provider of medical technology products. The Company designs, develops, manufactures and supplies single-use medical devices used by hospitals and healthcare providers for diagnostic and therapeutic procedures in critical care and surgical applications. The Company operates through six segments: Vascular North America; Anesthesia North America; Surgical North America; Europe, the Middle East and Africa (EMEA); Asia, and Original Equipment Manufacturer (OEM). The Company's products include oxygen therapy products, aerosol therapy products, spirometry products, and ventilation management products, which are offered under Hudson RCI brand. As of December 31, 2016, it manufactured its products at approximately 30 manufacturing sites, with manufacturing operations located in the Czech Republic, Germany, Malaysia, Mexico and the United States. Its all others businesses include single-use respiratory, urology and cardiac care products, as well as capital equipment.
More

Webull offers kinds of Teleflex Incorporated stock information, including NYSE:TFX real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, TFX stock news, and many more online research tools to help you make informed decisions.